Fabentech is a French biopharmaceutical company specialized in the development and production of emergency therapeutics to address the highest-priority biological threats. We support nations in building resilience by the stockpiling of medical countermeasures to respond to future pandemics and bioterror risks. Backed by trusted partnerships with defense and health authorities across Europe, we contribute directly to national and international preparedness and health security.
Fabentech is an integrated company, combining research, development, manufacturing, and deployment capabilities. Our antibody-based platform is a robust and validated technology capable of targeting multiple biological agents, enabling reliable supply for preparedness efforts worldwide.
Fabentech is an integrated company, combining research, development, manufacturing, and deployment capabilities. Our antibody-based platform is a robust and validated technology capable of targeting multiple biological agents, enabling reliable supply for preparedness efforts worldwide.


)